Yamamoto Yumiko, Fukushima Atsuki, Nishino Koji, Koura Yuji, Komatsu Tsutomu, Ueno Hisayuki
Department of Ophthalmology, Kochi Medical School, Kohasu, Nankoku, Japan.
Jpn J Ophthalmol. 2007 Jan-Feb;51(1):60-3. doi: 10.1007/s10384-006-0379-0. Epub 2007 Feb 9.
We present the clinical case reports of elderly Vogt-Koyanagi-Harada (VKH) disease patients, including the oldest patient at onset to date.
Four patients with VKH disease, whose ages at onset were 68 to 89 years, were treated at Kochi Medical School Hospital between December 2002 and September 2004.
Four elderly patients were diagnosed with VKH disease according to the International Revised Diagnostic Criteria for VKH disease. Two were treated with corticosteroid pulse therapy, but the other two could not tolerate high-dose steroid therapy and were treated with only topical corticosteroids. All had recurrences, which were treated effectively. None of these patients experienced recurrence after sunset glow fundus was observed in the follow-up period.
VKH disease is thought to be more common in younger people, but it is not as uncommon in elderly people as is generally believed. Among elderly VKH disease patients, some cannot tolerate high-dose corticosteroid therapy, so we need to treat these patients with only topical corticosteroids.
我们呈现老年Vogt-小柳-原田(VKH)病患者的临床病例报告,包括迄今为止发病时年龄最大的患者。
2002年12月至2004年9月期间,四名发病年龄在68至89岁的VKH病患者在高知医科大学医院接受治疗。
根据国际修订的VKH病诊断标准,四名老年患者被诊断为VKH病。两名患者接受了糖皮质激素脉冲治疗,但另外两名患者无法耐受高剂量激素治疗,仅接受了局部糖皮质激素治疗。所有患者均有复发,但均得到有效治疗。在随访期间,这些患者在出现晚霞样眼底后均未再复发。
VKH病通常被认为在年轻人中更常见,但在老年人中并不像普遍认为的那样罕见。在老年VKH病患者中,一些患者无法耐受高剂量糖皮质激素治疗,因此我们需要仅用局部糖皮质激素来治疗这些患者。